;PMID: 12687660
;source_file_2912.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..43] = [t:0..43]
;1)sentence:[e:49..148] = [t:49..148]
;2)section:[e:152..228] = [t:152..228]
;3)section:[e:232..305] = [t:232..305]
;4)sentence:[e:309..386] = [t:309..386]
;5)sentence:[e:387..516] = [t:387..516]
;6)sentence:[e:517..578] = [t:517..578]
;7)sentence:[e:579..726] = [t:579..726]
;8)sentence:[e:727..829] = [t:727..829]
;9)sentence:[e:830..980] = [t:830..980]
;10)sentence:[e:981..1133] = [t:981..1133]
;11)sentence:[e:1134..1223] = [t:1134..1223]
;12)sentence:[e:1224..1340] = [t:1224..1340]
;13)section:[e:1341..1372] = [t:1341..1372]
;14)section:[e:1376..1394] = [t:1376..1394]
;15)section:[e:1400..1412] = [t:1400..1412]
;16)section:[e:1416..1461] = [t:1416..1461]

;section 0 Span:0..43
;Am J Med Genet.  2003 May 1;118A(4):309-13.
(SEC
  (FRAG (NNP:[0..2] Am) (NNP:[3..4] J) (NNP:[5..8] Med) (NNP:[9..14] Genet)
        (.:[14..15] .) ('':[17..21] 2003) (NNP:[22..25] May)
        (.:[26..33] 1;118A-LRB-) (CD:[33..34] 4) (-RRB-:[34..35] -RRB-)
        (::[35..36] :) (CD:[36..39] 309) (HYPH:[39..40] -) (CD:[40..42] 13)
        (.:[42..43] .)))

;sentence 1 Span:49..148
;Homozygous inactivation of NF1 gene in a patient with familial NF1 and 
;disseminated neuroblastoma.
;[49..72]:variation-type:"Homozygous inactivation"
;[76..79]:gene-rna:"NF1"
;[103..115]:malignancy-type:"familial NF1"
;[134..147]:malignancy-type:"neuroblastoma"
(SENT
  (NP-HLN
    (NP (JJ:[49..59] Homozygous) (NN:[60..72] inactivation))
    (PP (IN:[73..75] of)
      (NP (NN:[76..79] NF1) (NN:[80..84] gene)))
    (PP (IN:[85..87] in)
      (NP
        (NP (DT:[88..89] a) (NN:[90..97] patient))
        (PP (IN:[98..102] with)
          (NP
            (NP (JJ:[103..111] familial) (NN:[112..115] NF1))
            (CC:[116..119] and)
            (NP (VBN:[121..133] disseminated) (NN:[134..147] neuroblastoma))))))
    (.:[147..148] .)))

;section 2 Span:152..228
;Origone P, Defferrari R, Mazzocco K, Lo Cunsolo C, De Bernardi B, Tonini GP.
(SEC
  (FRAG (NNP:[152..159] Origone) (NNP:[160..162] P,) (NNP:[163..173] Defferrari)
        (NNP:[174..175] R) (,:[175..176] ,) (NNP:[177..185] Mazzocco)
        (NNP:[186..188] K,) (NNP:[189..191] Lo) (NNP:[192..199] Cunsolo)
        (NNP:[200..201] C) (,:[201..202] ,) (NNP:[203..205] De)
        (NNP:[206..214] Bernardi) (NNP:[215..216] B) (,:[216..217] ,)
        (NNP:[218..224] Tonini) (NNP:[225..227] GP) (.:[227..228] .)))

;section 3 Span:232..305
;Department of Oncology, Biology and Genetics, University of Genoa, Italy.
(SEC
  (FRAG (NNP:[232..242] Department) (IN:[243..245] of) (NNP:[246..254] Oncology)
        (,:[254..255] ,) (NNP:[256..263] Biology) (CC:[264..267] and)
        (NNP:[268..276] Genetics) (,:[276..277] ,) (NNP:[278..288] University)
        (IN:[289..291] of) (NNP:[292..297] Genoa) (,:[297..298] ,)
        (NNP:[299..304] Italy) (.:[304..305] .)))

;sentence 4 Span:309..386
;Neurofibromatosis type 1 (NF1) patients are susceptible to tumor
;development.
;[309..333]:malignancy-type:"Neurofibromatosis type 1"
;[335..338]:malignancy-type:"NF1"
(SENT
  (S
    (NP-SBJ
      (NML
        (NML (NN:[309..326] Neurofibromatosis) (NN:[327..331] type)
             (CD:[332..333] 1))
        (NML (-LRB-:[334..335] -LRB-) (NN:[335..338] NF1)
             (-RRB-:[338..339] -RRB-)))
      (NNS:[340..348] patients))
    (VP (VBP:[349..352] are)
      (ADJP-PRD (JJ:[353..364] susceptible)
        (PP (TO:[365..367] to)
          (NP (NN:[368..373] tumor) (NN:[374..385] development)))))
    (.:[385..386] .)))

;sentence 5 Span:387..516
;In  the present study we describe a child with NF1 and disseminated
;neuroblastoma  whose death resulted from disease progression.
;[423..428]:malignancy-developmental-state:"child"
;[434..437]:malignancy-type:"NF1"
;[455..468]:malignancy-type:"neuroblastoma"
(SENT
  (S
    (PP (IN:[387..389] In)
      (NP (DT:[391..394] the) (JJ:[395..402] present) (NN:[403..408] study)))
    (NP-SBJ (PRP:[409..411] we))
    (VP (VBP:[412..420] describe)
      (NP
        (NP
          (NP (DT:[421..422] a) (NN:[423..428] child))
          (PP (IN:[429..433] with)
            (NP
              (NP (NN:[434..437] NF1))
              (CC:[438..441] and)
              (NP (VBN:[442..454] disseminated) (NN:[455..468] neuroblastoma)))))
        (SBAR
          (WHNP-1 (WP$:[470..475] whose) (NN:[476..481] death))
          (S
            (NP-SBJ-1 (-NONE-:[481..481] *T*))
            (VP (VBD:[482..490] resulted)
              (PP (IN:[491..495] from)
                (NP (NN:[496..503] disease) (NN:[504..515] progression))))))))
    (.:[515..516] .)))

;sentence 6 Span:517..578
;The mother had cafe-au-lait spots  suggesting a familial NF1.
;[565..577]:malignancy-type:"familial NF1"
(SENT
  (NP
    (NP-SBJ (DT:[517..520] The) (NN:[521..527] mother))
    (VP (VBD:[528..531] had)
      (NP
        (NML (FW:[532..536] cafe) (HYPH:[536..537] -) (FW:[537..539] au)
             (HYPH:[539..540] -) (FW:[540..544] lait))
        (NNS:[545..550] spots))
      (S-ADV
        (NP-SBJ (-NONE-:[550..550] *))
        (VP (VBG:[552..562] suggesting)
          (NP (DT:[563..564] a)
             (JJ:[565..573] familial) (NN:[574..577] NF1)))))
    (.:[577..578] .)))

;sentence 7 Span:579..726
;Neuroblastoma cells showed MYCN amplification and  chromosome 1p36 deletion,
;common features associated with tumor progression in  this malignancy.
;[579..598]:malignancy-type:"Neuroblastoma cells"
;[606..610]:gene-rna:"MYCN"
;[611..624]:variation-type:"amplification"
;[630..645]:variation-location:"chromosome 1p36"
;[646..654]:variation-type:"deletion"
(SENT
  (S
    (NP-SBJ (NN:[579..592] Neuroblastoma) (NNS:[593..598] cells))
    (VP (VBD:[599..605] showed)
      (NP
        (NP
          (NP (NN:[606..610] MYCN) (NN:[611..624] amplification))
          (CC:[625..628] and)
          (NP
             (NN:[630..640] chromosome) (NN:[641..645] 1p36)
            (NN:[646..654] deletion)))
        (,:[654..655] ,)
        (NP
          (NP (JJ:[656..662] common) (NNS:[663..671] features))
          (VP (VBN:[672..682] associated)
            (NP (-NONE-:[682..682] *))
            (PP-CLR (IN:[683..687] with)
              (NP (NN:[688..693] tumor) (NN:[694..705] progression)))
            (PP (IN:[706..708] in)
              (NP (DT:[710..714] this) (NN:[715..725] malignancy)))))))
    (.:[725..726] .)))

;sentence 8 Span:727..829
;The NF1 gene displayed a germline T --> C transition of intron  14 in both
;the proband and mother DNA.
;[731..734]:gene-rna:"NF1"
;[761..762]:variation-state-original:"T"
;[767..768]:variation-state-altered:"C"
;[769..779]:variation-type:"transition"
;[783..793]:variation-location:"intron  14"
(SENT
  (S
    (NP-SBJ (DT:[727..730] The) (NN:[731..734] NF1) (NN:[735..739] gene))
    (VP (VBD:[740..749] displayed)
      (NP
        (NP (DT:[750..751] a) (NN:[752..760] germline)
          (NML
            (NML (NN:[761..762] T)
              (PP (SYM:[763..766] -->)
                (NP (NN:[767..768] C)))))
          (NN:[769..779] transition))
        (PP (IN:[780..782] of)
          (NP (NN:[783..789] intron) (CD:[791..793] 14))))
      (PP (IN:[794..796] in)
        (NP (CC:[797..801] both)
          (NP (DT:[802..805] the) (NN:[806..813] proband))
          (CC:[814..817] and)
          (NP (NN:[818..824] mother) (NN:[825..828] DNA)))))
    (.:[828..829] .)))

;sentence 9 Span:830..980
;This mutation, not yet previously  described, occurs in a splicing donor site
;and produces a new mRNA variant  observed together with normal NF1 mRNA.
;[830..843]:variation-event:"This mutation"
;[971..974]:gene-rna:"NF1"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[830..834] This) (NN:[835..843] mutation))
      (,:[843..844] ,)
      (VP (RB:[845..848] not)
        (ADVP (RB:[849..852] yet))
        (ADVP-TMP (RB:[853..863] previously))
        (VBN:[865..874] described)
        (NP (-NONE-:[874..874] *))))
    (,:[874..875] ,)
    (VP
      (VP (VBZ:[876..882] occurs)
        (PP (IN:[883..885] in)
          (NP (DT:[886..887] a) (NN:[888..896] splicing) (NN:[897..902] donor)
              (NN:[903..907] site))))
      (CC:[908..911] and)
      (VP (VBZ:[912..920] produces)
        (NP
          (NP (DT:[921..922] a) (JJ:[923..926] new) (NN:[927..931] mRNA)
              (NN:[932..939] variant))
          (VP (VBN:[941..949] observed)
            (NP (-NONE-:[949..949] *))
            (ADVP (RB:[950..958] together)
              (PP (IN:[959..963] with)
                (NP (JJ:[964..970] normal) (NN:[971..974] NF1)
                    (NN:[975..979] mRNA))))))))
    (.:[979..980] .)))

;sentence 10 Span:981..1133
;Furthermore, the SSCP analysis of the  NF1 gene in tumor cells showed a
;somatic deletion encompassing the intron 26 and  27b of the paternal NF1
;allele.
;[1020..1023]:gene-rna:"NF1"
;[1061..1069]:variation-type:"deletion"
;[1087..1096]:variation-location:"intron 26"
;[1087..1093]...[1102..1105]:variation-location:"intron"..."27b"
;[1122..1125]:gene-rna:"NF1"
(SENT
  (S
    (ADVP (RB:[981..992] Furthermore))
    (,:[992..993] ,)
    (NP-SBJ
      (NP (DT:[994..997] the) (NN:[998..1002] SSCP) (NN:[1003..1011] analysis))
      (PP (IN:[1012..1014] of)
        (NP (DT:[1015..1018] the) (NN:[1020..1023] NF1) (NN:[1024..1028] gene)))
      (PP (IN:[1029..1031] in)
        (NP (NN:[1032..1037] tumor) (NNS:[1038..1043] cells))))
    (VP (VBD:[1044..1050] showed)
      (NP
        (NP (DT:[1051..1052] a) (JJ:[1053..1060] somatic)
            (NN:[1061..1069] deletion))
        (VP (VBG:[1070..1082] encompassing)
          (NP (DT:[1083..1086] the)
            (NML
              (NML
                (NML-1 (NN:[1087..1093] intron))
                (CD:[1094..1096] 26))
              (CC:[1097..1100] and)
              (NML
                (NML-1 (-NONE-:[1100..1100] *P*))
                (CD:[1102..1104] 27) (NN:[1104..1105] b))))
          (PP (IN:[1106..1108] of)
            (NP (DT:[1109..1112] the) (JJ:[1113..1121] paternal)
                (NN:[1122..1125] NF1) (NN:[1126..1132] allele))))))
    (.:[1132..1133] .)))

;sentence 11 Span:1134..1223
;Hence, neuroblastoma cells displayed both  somatic and germline mutation of
;the NF1 gene.
;[1141..1160]:malignancy-type:"neuroblastoma cells"
;[1214..1217]:gene-rna:"NF1"
(SENT
  (S
    (ADVP (RB:[1134..1139] Hence))
    (,:[1139..1140] ,)
    (NP-SBJ (NN:[1141..1154] neuroblastoma) (NNS:[1155..1160] cells))
    (VP (VBD:[1161..1170] displayed)
      (NP
        (NP (CC:[1171..1175] both)
          (NP (JJ:[1177..1184] somatic)
            (NML-1 (-NONE-:[1184..1184] *P*)))
          (CC:[1185..1188] and)
          (NP (NN:[1189..1197] germline)
            (NML-1 (NN:[1198..1206] mutation))))
        (PP (IN:[1207..1209] of)
          (NP (DT:[1210..1213] the) (NN:[1214..1217] NF1) (NN:[1218..1222] gene)))))
    (.:[1222..1223] .)))

;sentence 12 Span:1224..1340
;Our data suggest that, although  rare, neuroblastoma in patients with NF1 may
;display homozygous gene  inactivation.
;[1263..1276]:malignancy-type:"neuroblastoma"
;[1294..1297]:malignancy-type:"NF1"
;[1310..1339]:variation-type:"homozygous gene  inactivation"
(SENT
  (S
    (NP-SBJ (PRP$:[1224..1227] Our) (NNS:[1228..1232] data))
    (VP (VBP:[1233..1240] suggest)
      (SBAR (IN:[1241..1245] that) (,:[1245..1246] ,)
        (S
          (PP (IN:[1247..1255] although)
            (ADJP (JJ:[1257..1261] rare)))
          (,:[1261..1262] ,)
          (NP-SBJ
            (NP (NN:[1263..1276] neuroblastoma))
            (PP (IN:[1277..1279] in)
              (NP
                (NP (NNS:[1280..1288] patients))
                (PP (IN:[1289..1293] with)
                  (NP (NN:[1294..1297] NF1))))))
          (VP (MD:[1298..1301] may)
            (VP (VB:[1302..1309] display)
              (NP (JJ:[1310..1320] homozygous) (NN:[1321..1325] gene)
                  (NN:[1327..1339] inactivation)))))))
    (.:[1339..1340] .)))

;section 13 Span:1341..1372
;Copyright 2003 Wiley-Liss, Inc.
(SEC
  (FRAG (NN:[1341..1350] Copyright) (CD:[1351..1355] 2003)
        (NNP:[1356..1361] Wiley) (HYPH:[1361..1362] -) (NNP:[1362..1366] Liss)
        (,:[1366..1367] ,) (NNP:[1368..1372] Inc.)))

;section 14 Span:1376..1394
;Publication Types:
(SEC
  (FRAG (NNP:[1376..1387] Publication) (NNP:[1388..1393] Types)
        (::[1393..1394] :)))

;section 15 Span:1400..1412
;Case Reports
(SEC
  (FRAG (NN:[1400..1404] Case) (NNS:[1405..1412] Reports)))

;section 16 Span:1416..1461
;PMID: 12687660 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1416..1420] PMID) (::[1420..1421] :) (CD:[1422..1430] 12687660)
        (NN:[1431..1432] -LSB-) (NNP:[1432..1438] PubMed) (::[1439..1440] -)
        (NN:[1441..1448] indexed) (IN:[1449..1452] for)
        (NNP:[1453..1461] MEDLINE-RSB-)))
